Neurology 1999;53:1361
© 1999 American Academy of Neurology
Brief Communications
Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis
M. Fernandez-Arquero, PhD,
R. Arroyo, MD,
A. Rubio, BSc,
C. Martin, MD,
P. Vigil,
L. Conejero,
M. A. Figueredo, MD, PhD and
E. G. de la Concha, MD, PhD
From the Departments of Immunology (Dr. Fernandez-Arquero, A. Rubio, P. Vigil, L. Conejero, and Drs. Figueredo and de la Concha) and Neurology (Drs. Arroyo and Martin), San Carlos University Hospital, Madrid, Spain.
Address correspondence and reprint requests to Dr. Emilio Gómez de la Concha, Immunology Department, Hospital Universitario San Carlos, 28040 Madrid, Spain; e-mail: egomezdela{at}hcsc.insalud.es
The associations of three promoter polymorphisms in the tumor necrosis factor (TNFA) gene have been studied in 238 patients and 324 control subjects. A significant correlation was found between MS susceptibility and theTNFA-376 polymorphism. This association was independent of the human leukocyte antigen (HLA) class II association and the combined inheritance of HLA-DRB1*1501 and the TNFA-376A allele more than additively increased susceptibility to MS.
Key words: MSTumor necrosis factorHLA class IIPolymorphismGene association.
This article has been cited by other articles:

|
 |

|
 |
 
A Amirzargar, F Khosravi, S Dianat, F Hushmand, P Maryousef, A R Foroushani, J Lotfi, and B Nikbin
Profile of cytokine gene polymorphisms in Iranian multiple sclerosis patients
Multiple Sclerosis,
March 1, 2007;
13(2):
253 - 255.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Noguera-Pons, J. Borras-Blasco, I. Romero-Crespo, R. Anton-Torres, A. Navarro-Ruiz, and J. A. Gonzalez-Ferrandez
Optic Neuritis with Concurrent Etanercept and Isoniazid Therapy
Ann. Pharmacother.,
December 1, 2005;
39(12):
2131 - 2134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Mejico
Infliximab-Associated Retrobulbar Optic Neuritis
Arch Ophthalmol,
May 1, 2004;
122(5):
793 - 794.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Martinez, A. Rubio, E. Urcelay, M. Fernandez-Arquero, V. de las Heras, R. Arroyo, P. Villoslada, X. Montalban, and E.G. de la Concha
TNF-376A marks susceptibility to MS in the Spanish population: A replication study
Neurology,
March 9, 2004;
62(5):
809 - 810.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. G. De la Concha, M. Fernandez-Arquero, L. Gual, P. Vigil, A. Martinez, E. Urcelay, A. Ferreira, M. C. Garcia-Rodriguez, and G. Fontan
MHC Susceptibility Genes to IgA Deficiency Are Located in Different Regions on Different HLA Haplotypes
J. Immunol.,
October 15, 2002;
169(8):
4637 - 4643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. de Jong, T. W.J. Huizinga, E. Zanelli, M. J. Giphart, E. L.E.M. Bollen, B. M.J. Uitdehaag, C. H. Polman, and R. G.J. Westendorp
Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region
Neurology,
August 27, 2002;
59(4):
549 - 555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Foroozan, L. M. Buono, R. C. Sergott, and P. J. Savino
Retrobulbar Optic Neuritis Associated With Infliximab
Arch Ophthalmol,
July 1, 2002;
120(7):
985 - 987.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. G. Weinshenker, D. D. Hebrink, E. Atkinson, and O. H. Kantarci
Association of a tumor necrosis factor {alpha} polymorphism with MS susceptibility
Neurology,
October 9, 2001;
57(7):
1341 - 1342.
[Full Text]
[PDF]
|
 |
|
|